MIMETAS

In News

Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development - Business Wire

Business Wire - Aug 10, 2026

Bruker Takes Majority Stake in dutch MIMETAS as Organoid Technologies Move Into the Mainstream - European Biotechnology Magazine

European Biotechnology Magazine - Aug 12, 2026

Bruker Invests in Organ-on-a-Chip Firm Mimetas - Contract Pharma

Contract Pharma - Aug 10, 2026

Bruker Makes Majority Investment In MIMETAS To Expand Human-Relevant Drug Discovery Platform - Pulse 2.0

Pulse 2.0 - Aug 10, 2026

Bruker Makes Majority Investment in MIMETAS to Enhance Drug Discovery Efforts - SynBioBeta

SynBioBeta - Aug 11, 2026

Bruker takes majority stake in organ-on-a-chip firm MIMETAS - Investing.com

Investing.com - Aug 10, 2026

MIMETAS publishes breakthrough study on 3D blood-brain barrier model with unidirectional flow - News-Medical

News-Medical - Mar 05, 2026

Bruker Acquires Majority Stake in Mimetas to Expand Disease Biology Research - Yahoo Finance

Yahoo Finance - Aug 10, 2026

MIMETAS Receives Majority Investment From Bruker Corporation - FinSMEs

FinSMEs - Aug 10, 2026

Bruker takes majority stake in organ-on-a-chip maker MIMETAS - Dealroom

Dealroom - Aug 11, 2026

Netherlands: Bruker makes majority investment in Mimetas - Investors in Healthcare

Investors in Healthcare - Sep 02, 2026

Leiden research group sees spin-off grow into a success story - Universiteit Leiden

Universiteit Leiden - Aug 10, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment